男，2001年本科毕业于山东农业大学，2004年硕士毕业于南京农业大学，2009年在中科院动物所获得理学博士，主要研究方向是体细胞重编程。2009-2010在美国麻州大学畜牧兽医系进行博士后研究，主要从事早期胚胎发育的表观遗传调控；2010-2011在哈佛大学细胞学系从事TAP63对卵泡凋亡和胰腺组织特异干细胞影响机制的研究；2012年-2018年，在哈佛大学贝斯医学中心从事博士后研究，主要研究方向是蛋白质翻译后修饰对细胞周期，细胞增殖和癌症发生、发展以及药物耐药性的影响。2018年以人才引进入职吉林大学第一医院。目前主要的研究方向是利用基因编辑技术进行人类疾病大动物（猪）模型的研究，并用细胞生物学、生物化学、动物模型等研究信号通路在发育和疾病（遗传，癌症）中的作用及其翻译后修饰的调控机制。
近年来，共发表学术论文45篇，在Nature Medicine, Molecular Cell, Cancer Discovery, Nature Communication, Science Signaling, Protein Cell等国际著名学术期刊发表SCI研究论文或综述论文共33 篇，其中以第一作者或通讯作者（含并列）发表16篇。并获得美国卫生研究院（NIH）T32的科研奖励。


代表性研究论文


1. Yanpeng Ci*, Xiaoning Li*……, Yu Li#, Jianping Guo#, Xiangpeng Dai#. SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation. Protein Cell. 2018, 9(10): 879–889.
2. Xiangpeng Dai*, Wenjian Gan*, Xiaoning Li*, ……, Levi A. Garraway, Mark A. Rubin, Christopher E. Barbieri, Senthil K. Muthuswamy, Kwok-Kin Wong, Jiaoti Huang, James E. Bradner, Wenyi Wei. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors via stabilizing BRD4. Nat Med. 2017, 23(9):1063-1071.
3. Lixin Wan*, Ming Chen*, Juxiang Cao*, Xiangpeng Dai*, Qing Yin*, ……, Rutao Cui, Pier Paolo Pandolfi# and Wenyi Wei. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function. Cancer Discov. 2017, 7(4):424-441. (* co-first author)
4. Gan, W.*, Dai, X.*, Lunardi, A.*, Li, Z.*, ……, Huang, J., Pandolfi, P. P. and Wei, W. SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression. Molecular Cell. 2015, 59(6): 917-30. (* co-first author)
5. Cao, J.*, Dai, X.*, Wan, L.*, ……, Goding, C.R., Wang, Y., Wei, W#. and Cui, R. The E3 ligase APC/CCdh1 promotes ubiquitylation-mediated proteolysis of PAX3 to suppress melanocyte proliferation and melanoma growth. Science Signaling 2015，  8(392):ra87. (* co-first author)
6. Wang, Z.*, Dai, X.*, Zhong, J*, ……, Zou, L., and Wei, W. (2015) SCFβ-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation. Nature Communications 2015, 15(6):10185. (* co-first author)
7. Xiangpeng Dai*, Jie Hao*, Xiaojun Hou*, ……, Qi Zhou. Somatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydroxamide (CBHA), a histone deacetylase inhibitor. J Biol Chem. 2010, 285(40): 31002-10
8. Xiangpeng Dai, ……, Qi Zhou, Alice Jouneau, Liu Wang. Cloning efficiency following ES cell nuclear transfer is influenced by the methylation state of the donor nucleus altered by mutation of DNA methyltransferase 3a and 3b. Front. Biol. 2010, 5(5): 439-444
9. Julien Maruotti*, Xiangpeng Dai*, ……, Jean-Paul Renard, Qi Zhou, Alice Jouneau. Derivation of mouse epiblast stem cells from normal and somatic cell nuclear transfer embryos: similarity or dissimilarity? Stem Cells 2010, 28: 743-752. (* co-first author)
10. Amjad Riaz*, Xiaoyang Zhao*, Xiangpeng Dai*, ……, Qi Zhou. Mouse cloning and somatic cell reprogramming using electrofused blastomeres. Cell Research. 2010, 20:1-9. (* co-first author)
11. Dai Xiangpeng, Hao Jie, Zhou Qi. A modified culture method significantly improves the mice SCNT embryos development. Reproduction 2009, 138: 301–308.